STAT+: Most-favored nations policy makes drugmakers rethink launches abroad
Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:
Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:
comments(0)
5-min edit window · permanent after that